|
시장보고서
상품코드
2075308
저분자 프리필드 시린지 시장 : 유형별, 재료별, 용도별, 유통 채널별, 지역별Small Molecule Prefilled Syringes Market, By Type, By Material Type, By Application, By Distribution Channel, By Region |
||||||
저분자 프리필드 시린지 시장은 2026년에 221억 4,000만 달러 규모에 달할 것으로 추정되며, 2033년까지 320억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 221억 4,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 5.40% | 2033년 시장 규모 예측: | 320억 달러 |
프리필드 시린지는 사용 편의성 등, 기존의 바이알 포장에 비해 몇 가지 장점이 있습니다. 프리필드 시린지를 사용하면, 바이알에 들어 있는 의약품을 사용하기 전에 거쳐야 하는 절차가 필요 없어집니다. 또한, 미리 채워진 주사기에는 정확한 용량이 담겨 있으므로, 투여 실수를 방지하는 데에도 도움이 됩니다. 많은 제약사는 최종사용자가 정확한 용량을 확실하게 복용할 수 있도록 바이알에 최대 25%의 여유량을 채워 넣고 있습니다. 그러나 이러한 과다 주입은 실수를 초래할 가능성이 있지만, 프리필드 주사기를 사용하면 이러한 실수가 사실상 배제됩니다. 고가의 바이오의약품 도입에 따라, 특히 일부 백신의 공급이 부족하거나 가격이 매우 높은 경우, 폐기물 감축으로 이어진다는 점에서 이는 큰 장점이 됩니다.
시장 역학
시장 관계자들은 신제품 출시 및 승인에 주력하고 있으며, 이는 예측 기간 동안 전 세계 저분자 프리필드 주사기 시장의 성장에 기여할 것으로 전망됩니다. 예를 들어, 2018년 3월, 로슈 그룹 산하의 제넨테크는 미국 식품의약국(FDA)이 모든 형태의 당뇨병성 망막병증 치료제로 ‘루센티스(라니비주맙 주사액)’ 0.3 mg 프리필드 주사기(PFS)를 새로운 투여 방법으로 승인했다고 발표했습니다.
시장에 진출한 각 기업은 프리필드 주사기의 생산능력 확충에 주력하고 있습니다. 이에 따라 예측 기간 동안 시장 성장이 촉진될 것으로 예상됩니다. 예를 들어, 2019년 7월, 일본에 본사를 둔 테르모 주식회사는 자회사인 테르모 야마구치 D&D에 프리필드 주사기 추가 생산 시설을 건설할 것이라고 발표했습니다.
제품 출시에 주력하는 시장 관계자들의 움직임이 전 세계 저분자 프리필드 주사기 시장의 성장을 견인할 것으로 예상됩니다. 예를 들어, 2020년 3월, 대형 다국적 제약 기업인 Dr. Reddy's Laboratories Ltd.는 인도에서 '나르칸(나록손 염산염) 주사액 USP'와 치료상 동등한 제네릭 의약품인 ' '나록손 염산염 주사액 USP, 2 mg/2 mL(1 mg/mL) 1회 투여용 프리필드 주사기'의 출시를 발표했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음 매개변수를 바탕으로 전 세계 저분자 프리필드 주사기 시장의 주요 기업 개요을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획입니다.
- 본 보고서에서 도출된 인사이트는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내릴 수 있도록 돕습니다.
- '세계 저분자 프리필드 주사기 시장' 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 저분자 프리필드 주사기 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 저분자 프리필드 시린지 시장 : 유형별, 2021-2033년
제5장 세계의 저분자 프리필드 시린지 시장 : 재료별, 2021-2033년
제6장 세계의 저분자 프리필드 시린지 시장 : 용도별, 2021-2033년
제7장 세계의 저분자 프리필드 시린지 시장 : 유통 채널별, 2021-2033년
제8장 세계의 저분자 프리필드 시린지 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSM 26.07.09Small Molecule Prefilled Syringes Market is estimated to be valued at USD 22.14 Bn in 2026 and is expected to reach USD 32.00 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 22.14 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.40% | 2033 Value Projection: | USD 32.00 Bn |
Prefilled syringes have several advantages over traditional vial packaging, including ease of use. Prefilled syringes obviate the need for the processes that are required before using a drug in a vial. It also helps to eliminate dosing errors because prefilled syringes contain the exact dose. Many pharmaceutical manufacturers overfill vials by up to 25% to ensure that the end user receives the correct dose. However, overfilling can result in errors that are virtually eliminated with prefilled syringes. With the introduction of more expensive biotech drugs, this is advantageous because it means less waste, particularly if some vaccines are in short supply or extremely expensive.
Market Dynamics
Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.
Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.
Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global small molecule prefilled syringes market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann-La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, and McKesson Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global small molecule prefilled syringes market
Detailed Segmentation:
- Global Small Molecule Prefilled Syringes Market, By Drug Class (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- Global Small Molecule Prefilled Syringes Market, By Material Type (Revenue, USD Bn, 2021 - 2033)
- Glass
- Plastic & Polymer
- Global Small Molecule Prefilled Syringes Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Small Molecule Prefilled Syringes Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.S.
- Canada
- By Drug Class:
- Latin America
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Class:
- Europe
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Drug Class:
- Asia Pacific
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Drug Class:
- Middle East
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Drug Class:
- Africa
- By Drug Class:
- Cardiovascular Drugs
- Neurology Drugs
- Analgesics
- Adjuvants
- Others
- By Material Type:
- Glass
- Plastic & Polymer
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Drug Class:
- Company Profiles
- Sanofi *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Viatris Inc. (Mylan N.V.)
- AstraZeneca Plc
- F. Hoffmann-La Roche AG (Genentech, Inc.)
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Dr. Reddy's Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.
- Fresenius Kabi AG
- McKesson Corporation.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Material Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Market Trends
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER'S Analysis
- Industry Trends
- Product Launches and Approvals
4. Global Small Molecule Prefilled Syringes Market, By Type, 2021- 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Single-chamber Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Dual-chamber Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Customized Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
5. Global Small Molecule Prefilled Syringes Market, By Material Type, 2021- 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Plastic & Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
6. Global Small Molecule Prefilled Syringes Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Opthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Anaphylaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Others (Thrombosis, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
7. Global Small Molecule Prefilled Syringes Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Global Small Molecule Prefilled Syringes Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, andY-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 -2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- BD
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cytiva
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Gaplast
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ascendia Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Viatris Inc. (Mylan N.V.)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Fresenius Kabi AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- McKesson Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Analysts' Views
- BD
10. Section
- References
- Research Methodology
- About us and Sales Contact
